Levofloxacin News
Oculus Innovative Sciences Announces Fiscal Third Quarter 2008 Quarterly Results and Clinical Update
Oculus Innovative Sciences, Inc. today announced quarterly results for its fiscal third quarter of 2008, ended December 31, 2007.
FDA Approves Levaquin Short-Course Therapy
The FDA has approved the use of the five-day, once-daily regimen of Johnson & Johnson’s (J&J) Levaquin 750 mg for the treatment of complicated urinary tract infections and acute pyelonephritis.
Levofloxacin- vs. Ranitidine Bismuth Citrate-Containing Therapy After H. pylori Treatment Failure
Aim: Ranitidine bismuth citrate and levofloxacin-based regimen may be an alternative to quadruple therapy after Helicobacter pylori eradication failure. Our aim was to compare two 7-day triple second-line regimens containing...
Successful Treatment of Klebsiella rhinoscleromatis Bacteremia with Levofloxacin
A 71-year-old Caucasian woman was admitted to the hospital with right-sided weakness and slurred speech.
Levofloxacin Effective for Middle Ear Infection in Children
The fluoroquinolone levofloxacin is highly effective against bacterial pathogens associated with acute otitis media in children, according to researchers.